CIM Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,648	Closed	-$233K	–	332
2021 Q2	$233K	Buy	+1,648	New	+$233K	0.07%	264
2020 Q4	–	Sell	-2,053	Closed	-$200K	–	305
2020 Q3	$200K	Buy	2,053 +29	+1%	+$2.83K	0.08%	239
2020 Q2	$316K	Buy	+2,024	New	+$316K	0.13%	163